Management of end-stage kidney failure in patients with adult polycystic kidney disease

Authors

  • Tunde Campbell Consultant Transplant Surgeon, Kidney & Pancreas Transplant Centre, Manchester University Hospitals NHS Foundation Trust, Manchester Royal Infirmary, Oxford Road, Manchester, United Kingdom

DOI:

https://doi.org/10.51496/jogm.v1.9

Keywords:

Kidney, Polycystic, Genetic, Autosomal, Nephrectomy, Transplant

References

Cornec-Le Gall E, Audrézet M-P, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al. The PROPKD score: A new algorithm to predict renal survival in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 2016; 27: 942–51. doi: 10.1681/ASN.2015010016

Torres VE, Chapman, AB, Devuyst O, et al. Tolvaptan in later-stage autosomal dominant polycystic kidney disease. N Engl J Med 2017; 377: 1930–42. doi: 10.1056/NEJMoa1710030

Jacquet A, Pallet N, Kessler M. Outcomes of renal transplantation in patients with autosomal dominant polycystic kidney disease: a nationwide longitudinal study. Transpl Int 2011; 24: 582–7. doi: 10.1111/j.1432-2277.2011.01237.x

Downloads

Published

26-02-2021

How to Cite

Campbell, T. . (2021). Management of end-stage kidney failure in patients with adult polycystic kidney disease. Journal of Global Medicine, 1(1), e9. https://doi.org/10.51496/jogm.v1.9

Issue

Vol. 1 No. 1 (2021)

Section

Clinical Notes

Categories

License

Copyright (c) 2021 Tunde Campbell

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Crossref
Scopus
Google Scholar
Europe PMC